Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Luminex Corp (NASDAQ:LMNX)

21.14
Delayed Data
As of Jun 23
 +0.12 / +0.57%
Today’s Change
17.64
Today|||52-Week Range
23.75
+4.50%
Year-to-Date
LMNX Regular Dividend: LMNX began trading ex-dividend on 06/21/17. A $0.06 dividend will be paid to shareholders of record as of 06/23/17.
Want to Combat Market Volatility? Buy 5 Low Beta Stocks
Jun 23 / Zacks.com - Paid Partner Content
Luminex (LMNX) Scores a Strong Buy Right Now: Here's How
Jun 20 / Zacks.com - Paid Partner Content
Evolent Health (EVH) Prices 4.5M Follow-On Share Offering
Jun 23 / Zacks.com - Paid Partner Content
PRA Health (PRAH) Shares Rally on Partnership with Jumo
Jun 20 / Zacks.com - Paid Partner Content
Luminex (LMNX) Banks on Portfolio Strength, View Impressive
Jun 22 / Zacks.com - Paid Partner Content
Neogen Offers NeoSeek Genomic Services to Ensure Food Safety
Jun 20 / Zacks.com - Paid Partner Content
PRA Health Hits a 52-Week High on Strategic Acquisitions
Jun 22 / Zacks.com - Paid Partner Content
DENTSPLY (XRAY) Renews Partnership with Pacific Dental
Jun 19 / Zacks.com - Paid Partner Content
Medidata Solutions (MDSO) Set to Join the S&P 400 Index
Jun 21 / Zacks.com - Paid Partner Content
Pacific Biosciences (PACB) Prices Offering of Common Stock
Jun 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close21.02
Today’s open21.00
Day’s range20.82 - 21.16
Volume513,411
Average volume (3 months)228,828
Market cap$928.6M
Dividend yield1.14%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-62.79%
Earnings growth (this year)+6.55%
Earnings growth (next 5 years)-5.05%
Revenue growth (last year)+13.85%
P/E ratio66.1
Price/Sales3.22
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
OSUROraSure Technologies...+0.26+1.70%
BEATBioTelemetry Inc+0.30+1.02%
CSIICardiovascular Syste...-0.04-0.13%
KTWOK2M Group Holdings I...+0.41+1.74%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$270.6M
Annual profit (last year)$13.8M
Net profit margin5.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nachum Shamir
Chief Financial Officer, Treasurer &
SVP-Finance
Harriss T. Currie
Corporate headquarters
Austin, Texas

Forecasts